Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 23 results.
User Information
Export Records
  1. 1.   The interaction of spongistatin 1 with tubulin
  2. Bai,Ruoli; Smith, Amos B; Pettit, George R; Hamel,Ernest
  3. Archives of Biochemistry and Biophysics. 2022, May 17; 109296.
  1. 2.   Optimization of Ultrasound-Assisted Extraction, HPLC and UHPLC-ESI-Q-TOF-MS/MS Analysis of Main Macamides and Macaenes from Maca (Cultivars of Lepidium meyenii Walp)
  2. Chen, Shu-Xiao; Li, Ke-Ke; Pubu, Duoji; Jiang, Si-Ping; Chen, Bin; Chen, Li-Rong; Yang, Zhen; Ma, Chao; Gong, Xiao-Jie
  3. Molecules (Basel, Switzerland). 2017, Dec 10; 22(12): 2196.
  1. 3.   Factors That Contribute to Assay Variation in Quantitative Analysis of Sex Steroid Hormones Using Liquid and Gas Chromatography-Mass Spectrometry
  2. Xu, X.; Veenstra, T. D.
  3. Journal of Chemical Education. 2012, Feb; 89(2): 230-233.
  1. 4.   A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma
  2. Peer, C. J.; Spencer, S. D.; VanDenBerg, D. A. H.; Pacanowski, M. A.; Horenstein, R. B.; Figg, W. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2012, Jan; 880: 132-139.
  1. 5.   Quantitation of free and total bisphenol A in human urine using liquid chromatography-tandem mass spectrometry
  2. Fox, S. D.; Falk, R. T.; Veenstra, T. D.; Issaq, H. J.
  3. Journal of Separation Science. 2011, Jun; 34(11): 1268-1274.
  1. 6.   Optimization of a Cyclic Peptide Inhibitor of Ser/Thr Phosphatase PPM1D (Wip1)
  2. Hayashi, R.; Tanoue, K.; Durell, S. R.; Chatterjee, D. K.; Jenkins, L. M. M.; Appella, D. H.; Appella, E.
  3. Biochemistry. 2011, May; 50(21): 4537-4549.
  1. 7.   Electrophoresis and liquid chromatography/tandem mass spectrometry in disease biomarker discovery
  2. Issaq, H. J.; Blonder, J.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2009 877(13): 1222-1228.
  1. 8.   LC-MS in metabonomics: Optimization of experimental conditions for the analysis of metabolites in human urine
  2. Waybright, T. J.; Van, Q. N.; Muschik, G. M.; Conrads, T. P.; Veenstra, T. D.; Issaq, H. J.
  3. Journal of Liquid Chromatography & Related Technologies. 2006 29(17): 2475-2497.
  1. 9.   Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin 1 (IL 1)
  2. Yoshimura, T.; Matsushima, K.; Oppenheim, J. J.; Leonard, E. J.
  3. Journal of Immunology. 2005, NOV 1; 175(9): 5569-5574.
  1. 10.   Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells
  2. Ben-Kasus, T.; Ben-Zvi, Z.; Marquez, V. E.; Kelley, J. A.; Agbaria, R.
  3. Biochemical Pharmacology. 2005, JUL 1; 70(1): 121-133.
  1. 11.   Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O-6-benzylguanine
  2. Fishel, M. L.; Ganicsik, M. P.; Delaney, S. M.; Zuhowski, E. G.; Maher, V. M.; Karrison, T.; Moschel, R. C.; Egorin, M. J.; Dolan, M. E.
  3. Cancer Chemotherapy and Pharmacology. 2005, APR; 55(4): 333-342.
  1. 12.   Quantitative determination of antalarmin, a novel corticotropin-releasing hormone receptor-1 antagonist, in canine plasma by HPLC-MS
  2. Fox, S. D.; Roman, J. M.; Cizza, G.; Veenstra, T. D.; Issaq, H. J.
  3. Journal of Separation Science. 2005, MAR; 28(4): 332-336.
  1. 13.   Utilization of a common pathway for the synthesis of high affinity macrocyclic Grh2 SH2 domain-binding peptide mimetics that differ in the configuration at one ring junction
  2. Shi, Z. D.; Karki, R. G.; Worthy, K. M.; Bindu, L. K.; Nicklaus, M. C.; Fisher, R. J.; Burke, T. R.
  3. Chemistry & Biodiversity. 2005 2(4): 447-456.
  1. 14.   Characterization and analysis of thermal denaturation of antibodies by size exclusion high-performance liquid chromatography with quadruple detection
  2. Hartmann, W. K.; Saptharishi, N.; Yang, X. Y.; Mitra, G.; Soman, G.
  3. Analytical Biochemistry. 2004 325(2): 227-239.
  1. 15.   Gymnangiamide, a cytotoxic pentapeptide from the marine hydroid Gymnangium regae
  2. Milanowski, D. J.; Gustafson, K. R.; Rashid, M. A.; Pannell, L. K.; McMahon, J. B.; Boyd, M. R.
  3. Journal of Organic Chemistry. 2004 69(9): 3036-3042.
  1. 16.   Direct ampholyte-free liquid-phase isoelectric peptide focusing: Application to the human serum proteome
  2. Xiao, Z.; Conrads, T. P.; Lucas, D. A.; Janini, G. M.; Schaefer, C. F.; Buetow, K. H.; Issaq, H. J.; Veenstra, T. D.
  3. Electrophoresis. 2004 25(1): 128-133.
  1. 17.   Effect of experimental parameters on the HPLC separation of peptides and proteins
  2. Issaq, H. J.; Fox, S. D.; Mahadevan, M.; Conrads, T. P.; Veenstra, T. D.
  3. Journal of Liquid Chromatography & Related Technologies. 2003 26(14): 2255-2283.
  1. 18.   Qualitative thin-layer and high-performance liquid chromatographic analysis of 1-substituted diazen-1-ium-1,2- diolates on aminopropyl-bonded silica gel
  2. Fitzhugh, A. L.; Anadu, N. O.; Waterhouse, D. J.; Hrabie, J. A.; Saavedra, J. E.; Keefer, L. K.
  3. Analytical Biochemistry. 2002 301(1): 97-102.
  1. 19.   DHPLC screening of cystic fibrosis gene mutations
  2. Ravnik-Glavac, M.; Atkinson, A.; Glavac, D.; Dean, M.
  3. Human Mutation. 2002 19(4): 374-383.
  1. 20.   Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods
  2. Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2001 17(3): 210-219.
  1. 21.   Does the interconversion of polysulfur compounds proceed via hypervalent intermediates? - An ab initio MO study
  2. Steudel, R.; Steudel, Y.; Miaskiewicz, K.
  3. Chemistry-a European Journal. 2001 7(15): 3281-3290.
  1. 22.   Signature-based analysis of MET proto-oncogene mutations using DHPLC
  2. Nickerson, M. L.; Weirich, G.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2000 16(1): 68-76.
  1. 23.   Determination of Flavopiridol (L86 8275 Nsc 649890) in Human Plasma By Reversed-Phase Liquid Chromatography With Electrochemical Detection
  2. Stinson, S. F.; Hill, K.; Siford, T. J.; Phillips, L. R.; Daw, T. W.
  3. Cancer Chemotherapy and Pharmacology. 1998 42(4): 261-265.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel